Cargando…

A Care Pathway Analysis of Tuberculosis Patients in Benin: Highlights on Direct Costs and Critical Stages for an Evidence-Based Decision-Making

BACKGROUND: Free tuberculosis control fail to protect patients from substantial medical and non-medical expenditure, thus a greater degree of disaggregation of patient cost is needed to fully capture their context and inform policymaking. METHODS: A retrospective cross-sectional study was conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Laokri, Samia, Amoussouhui, Arnaud, Ouendo, Edgard M., Hounnankan, Athanase Cossi, Anagonou, Séverin, Gninafon, Martin, Kassa, Ferdinand, Tawo, Léon, Dujardin, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014559/
https://www.ncbi.nlm.nih.gov/pubmed/24810007
http://dx.doi.org/10.1371/journal.pone.0096912
_version_ 1782315196046376960
author Laokri, Samia
Amoussouhui, Arnaud
Ouendo, Edgard M.
Hounnankan, Athanase Cossi
Anagonou, Séverin
Gninafon, Martin
Kassa, Ferdinand
Tawo, Léon
Dujardin, Bruno
author_facet Laokri, Samia
Amoussouhui, Arnaud
Ouendo, Edgard M.
Hounnankan, Athanase Cossi
Anagonou, Séverin
Gninafon, Martin
Kassa, Ferdinand
Tawo, Léon
Dujardin, Bruno
author_sort Laokri, Samia
collection PubMed
description BACKGROUND: Free tuberculosis control fail to protect patients from substantial medical and non-medical expenditure, thus a greater degree of disaggregation of patient cost is needed to fully capture their context and inform policymaking. METHODS: A retrospective cross-sectional study was conducted on a convenience sample of six health districts of Southern Benin. From August 2008 to February 2009, we recruited all smear-positive pulmonary tuberculosis patients treated under the national strategy in the selected districts. Direct out-of-pocket costs associated with tuberculosis, time delays, and care-seeking pattern were collected from symptom onset to end of treatment. RESULTS: Population description and outcome data were reported for 245 patients of whom 153 completed their care pathway. For them, the median overall direct cost was USD 183 per patient. Payments to traditional healers, self-medication drugs, travel, and food expenditures contributed largely to this cost burden. Patient, provider, and treatment delays were also reported. Pre-diagnosis and intensive treatment stages were the most critical stages, with median expenditure of USD 43 per patient and accounting for 38% and 29% of the overall direct cost, respectively. However, financial barriers differed depending on whether the patient lived in urban or rural areas. CONCLUSIONS: This study delivers new evidence about bottlenecks encountered during the TB care pathway. Financial barriers to accessing the free-of-charge tuberculosis control strategy in Benin remain substantial for low-income households. Irregular time delays and hidden costs, often generated by multiple visits to various care providers, impair appropriate patient pathways. Particular attention should be paid to pre-diagnosis and intensive treatment. Cost assessment and combined targeted interventions embodied by a patient-centered approach on the specific critical stages would likely deliver better program outcomes.
format Online
Article
Text
id pubmed-4014559
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40145592014-05-14 A Care Pathway Analysis of Tuberculosis Patients in Benin: Highlights on Direct Costs and Critical Stages for an Evidence-Based Decision-Making Laokri, Samia Amoussouhui, Arnaud Ouendo, Edgard M. Hounnankan, Athanase Cossi Anagonou, Séverin Gninafon, Martin Kassa, Ferdinand Tawo, Léon Dujardin, Bruno PLoS One Research Article BACKGROUND: Free tuberculosis control fail to protect patients from substantial medical and non-medical expenditure, thus a greater degree of disaggregation of patient cost is needed to fully capture their context and inform policymaking. METHODS: A retrospective cross-sectional study was conducted on a convenience sample of six health districts of Southern Benin. From August 2008 to February 2009, we recruited all smear-positive pulmonary tuberculosis patients treated under the national strategy in the selected districts. Direct out-of-pocket costs associated with tuberculosis, time delays, and care-seeking pattern were collected from symptom onset to end of treatment. RESULTS: Population description and outcome data were reported for 245 patients of whom 153 completed their care pathway. For them, the median overall direct cost was USD 183 per patient. Payments to traditional healers, self-medication drugs, travel, and food expenditures contributed largely to this cost burden. Patient, provider, and treatment delays were also reported. Pre-diagnosis and intensive treatment stages were the most critical stages, with median expenditure of USD 43 per patient and accounting for 38% and 29% of the overall direct cost, respectively. However, financial barriers differed depending on whether the patient lived in urban or rural areas. CONCLUSIONS: This study delivers new evidence about bottlenecks encountered during the TB care pathway. Financial barriers to accessing the free-of-charge tuberculosis control strategy in Benin remain substantial for low-income households. Irregular time delays and hidden costs, often generated by multiple visits to various care providers, impair appropriate patient pathways. Particular attention should be paid to pre-diagnosis and intensive treatment. Cost assessment and combined targeted interventions embodied by a patient-centered approach on the specific critical stages would likely deliver better program outcomes. Public Library of Science 2014-05-08 /pmc/articles/PMC4014559/ /pubmed/24810007 http://dx.doi.org/10.1371/journal.pone.0096912 Text en © 2014 Laokri et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Laokri, Samia
Amoussouhui, Arnaud
Ouendo, Edgard M.
Hounnankan, Athanase Cossi
Anagonou, Séverin
Gninafon, Martin
Kassa, Ferdinand
Tawo, Léon
Dujardin, Bruno
A Care Pathway Analysis of Tuberculosis Patients in Benin: Highlights on Direct Costs and Critical Stages for an Evidence-Based Decision-Making
title A Care Pathway Analysis of Tuberculosis Patients in Benin: Highlights on Direct Costs and Critical Stages for an Evidence-Based Decision-Making
title_full A Care Pathway Analysis of Tuberculosis Patients in Benin: Highlights on Direct Costs and Critical Stages for an Evidence-Based Decision-Making
title_fullStr A Care Pathway Analysis of Tuberculosis Patients in Benin: Highlights on Direct Costs and Critical Stages for an Evidence-Based Decision-Making
title_full_unstemmed A Care Pathway Analysis of Tuberculosis Patients in Benin: Highlights on Direct Costs and Critical Stages for an Evidence-Based Decision-Making
title_short A Care Pathway Analysis of Tuberculosis Patients in Benin: Highlights on Direct Costs and Critical Stages for an Evidence-Based Decision-Making
title_sort care pathway analysis of tuberculosis patients in benin: highlights on direct costs and critical stages for an evidence-based decision-making
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014559/
https://www.ncbi.nlm.nih.gov/pubmed/24810007
http://dx.doi.org/10.1371/journal.pone.0096912
work_keys_str_mv AT laokrisamia acarepathwayanalysisoftuberculosispatientsinbeninhighlightsondirectcostsandcriticalstagesforanevidencebaseddecisionmaking
AT amoussouhuiarnaud acarepathwayanalysisoftuberculosispatientsinbeninhighlightsondirectcostsandcriticalstagesforanevidencebaseddecisionmaking
AT ouendoedgardm acarepathwayanalysisoftuberculosispatientsinbeninhighlightsondirectcostsandcriticalstagesforanevidencebaseddecisionmaking
AT hounnankanathanasecossi acarepathwayanalysisoftuberculosispatientsinbeninhighlightsondirectcostsandcriticalstagesforanevidencebaseddecisionmaking
AT anagonouseverin acarepathwayanalysisoftuberculosispatientsinbeninhighlightsondirectcostsandcriticalstagesforanevidencebaseddecisionmaking
AT gninafonmartin acarepathwayanalysisoftuberculosispatientsinbeninhighlightsondirectcostsandcriticalstagesforanevidencebaseddecisionmaking
AT kassaferdinand acarepathwayanalysisoftuberculosispatientsinbeninhighlightsondirectcostsandcriticalstagesforanevidencebaseddecisionmaking
AT tawoleon acarepathwayanalysisoftuberculosispatientsinbeninhighlightsondirectcostsandcriticalstagesforanevidencebaseddecisionmaking
AT dujardinbruno acarepathwayanalysisoftuberculosispatientsinbeninhighlightsondirectcostsandcriticalstagesforanevidencebaseddecisionmaking
AT laokrisamia carepathwayanalysisoftuberculosispatientsinbeninhighlightsondirectcostsandcriticalstagesforanevidencebaseddecisionmaking
AT amoussouhuiarnaud carepathwayanalysisoftuberculosispatientsinbeninhighlightsondirectcostsandcriticalstagesforanevidencebaseddecisionmaking
AT ouendoedgardm carepathwayanalysisoftuberculosispatientsinbeninhighlightsondirectcostsandcriticalstagesforanevidencebaseddecisionmaking
AT hounnankanathanasecossi carepathwayanalysisoftuberculosispatientsinbeninhighlightsondirectcostsandcriticalstagesforanevidencebaseddecisionmaking
AT anagonouseverin carepathwayanalysisoftuberculosispatientsinbeninhighlightsondirectcostsandcriticalstagesforanevidencebaseddecisionmaking
AT gninafonmartin carepathwayanalysisoftuberculosispatientsinbeninhighlightsondirectcostsandcriticalstagesforanevidencebaseddecisionmaking
AT kassaferdinand carepathwayanalysisoftuberculosispatientsinbeninhighlightsondirectcostsandcriticalstagesforanevidencebaseddecisionmaking
AT tawoleon carepathwayanalysisoftuberculosispatientsinbeninhighlightsondirectcostsandcriticalstagesforanevidencebaseddecisionmaking
AT dujardinbruno carepathwayanalysisoftuberculosispatientsinbeninhighlightsondirectcostsandcriticalstagesforanevidencebaseddecisionmaking